Bionomics (BNOX) Short Interest Ratio & Short Volume → Did Intel Just Dethrone Nvidia? (From Chaikin Analytics) (Ad) Free BNOX Stock Alerts $0.93 +0.01 (+1.09%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Bionomics Short Interest DataCurrent Short Volume118,200 sharesPrevious Short Volume165,600 sharesChange Vs. Previous Month-28.62%Dollar Volume Sold Short$114,441.24Short Interest Ratio / Days to Cover1.0Last Record DateApril 30, 2024Outstanding Shares8,160,000 sharesPercentage of Shares Shorted1.45%Today's Trading Volume80,648 sharesAverage Trading Volume170,627 sharesToday's Volume Vs. Average47% Short Selling Bionomics ? Sign up to receive the latest short interest report for Bionomics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBNOX Short Interest Over TimeBNOX Days to Cover Over TimeBNOX Percentage of Float Shorted Over Time Ad Porter & CompanyTruth about Trump you’ve never heardEverything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here. Bionomics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024118,200 shares $114,441.24 -28.6%N/A1 $0.97 4/15/2024165,600 shares $162,122.40 -35.9%N/A1.1 $0.98 3/31/2024258,400 shares $266,152.00 +344.0%N/A1.2 $1.03 3/15/202458,200 shares $59,946.00 -32.5%N/A0.2 $1.03 2/29/202486,200 shares $106,888.00 -62.8%N/A0.4 $1.24 2/15/2024231,500 shares $289,375.00 -8.2%N/A0.9 $1.25 Get the Latest News and Ratings for BNOX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bionomics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024252,300 shares $243,974.10 +258.4%N/A1.1 $0.97 1/15/202470,400 shares $78,848.00 +8.6%N/A0.3 $1.12 12/31/202364,800 shares $95,904.00 +136.5%N/A0.2 $1.48 12/15/202327,400 shares $32,606.00 -18.0%N/A0 $1.19 11/30/202333,400 shares $44,088.00 -10.5%N/A0 $1.32 11/15/202337,300 shares $73,108.00 -57.6%N/A0 $1.96 10/31/202388,000 shares $216,480.00 -62.7%N/A0 $2.46 10/15/2023235,900 shares $915,292.00 +104.6%N/A0.1 $3.88 9/30/2023115,300 shares $311,310.00 -54.5%N/A0 $2.70 9/15/2023253,600 shares $306,856.00 -59.1%N/A1.1 $1.21 8/31/2023620,400 shares $1.12 million +922.1%N/A3.2 $1.80 8/15/202360,700 shares $88,015.00 +20,133.3%N/A1.7 $1.45 7/31/2023300 shares $492.00 -97.3%N/A0 $1.64 7/15/202311,100 shares $29,857.89 +13.3%N/A1.3 $2.69 6/30/20239,800 shares $21,560.00 -32.4%N/A0.8 $2.20 6/15/202314,500 shares $34,800.00 +130.2%N/A0.5 $2.40 5/31/20236,300 shares $13,986.00 -20.3%N/A0.1 $2.22 5/15/20237,900 shares $22,910.00 +690.0%N/A0.1 $2.90 4/30/20231,000 shares $2,250.00 -90.4%N/A0 $2.25 4/15/202310,400 shares $23,816.00 +1.0%N/A0.1 $2.29 3/31/202310,300 shares $26,780.00 +37.3%N/A0.1 $2.60 3/15/20237,500 shares $20,625.00 +29.3%N/A0.1 $2.75 2/28/20235,800 shares $17,400.00 +81.3%N/A0.1 $3.00 2/15/20233,200 shares $12,800.00 -39.6%N/A0.3 $4.00 1/31/20235,300 shares $21,200.00 +278.6%N/A0.5 $4.00 1/15/20231,400 shares $5,992.00 +40.0%N/A0.2 $4.28 12/30/20221,000 shares $4,650.00 +150.0%N/A0.2 $4.65 12/15/2022400 shares $2,720.00 -71.4%N/A0.1 $6.80 11/30/20221,400 shares $9,800.00 -26.3%N/A0.2 $7.00 11/15/20221,900 shares $16,150.00 No ChangeN/A0.4 $8.50 10/31/20221,900 shares $15,675.00 +216.7%N/A1 $8.25 10/15/2022600 shares $5,280.00 -62.5%N/A0.4 $8.80 9/30/20221,600 shares $10,032.00 No ChangeN/A1 $6.27 9/15/20221,600 shares $11,808.00 -42.9%N/A1.2 $7.38Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. BNOX Short Interest - Frequently Asked Questions What is Bionomics' current short interest? Short interest is the volume of Bionomics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 118,200 shares of BNOX short. Learn More on Bionomics' current short interest. What is a good short interest ratio for Bionomics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNOX shares currently have a short interest ratio of 1.0. Learn More on Bionomics's short interest ratio. Is Bionomics' short interest increasing or decreasing? Bionomics saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 118,200 shares, a drop of 28.6% from the previous total of 165,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Bionomics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Bionomics: Virios Therapeutics, Inc. (1.24%), Cyclerion Therapeutics, Inc. (0.99%), Cadrenal Therapeutics, Inc. (0.80%), Trevena, Inc. (0.08%), NuCana plc (1.21%), Vaccinex, Inc. (2.40%), eFFECTOR Therapeutics, Inc. (3.12%), Biofrontera Inc. (0.75%), Hepion Pharmaceuticals, Inc. (1.19%), Pasithea Therapeutics Corp. (1.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Bionomics stock? Short selling BNOX is an investing strategy that aims to generate trading profit from Bionomics as its price is falling. BNOX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bionomics? A short squeeze for Bionomics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BNOX, which in turn drives the price of the stock up even further. How often is Bionomics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNOX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Virios Therapeutics Short Interest Data Cyclerion Therapeutics Short Interest Data Cadrenal Therapeutics Short Interest Data Trevena Short Interest Data NuCana Short Interest Data Vaccinex Short Interest Data eFFECTOR Therapeutics Short Interest Data Biofrontera Short Interest Data Hepion Pharmaceuticals Short Interest Data Pasithea Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNOX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper